4Li JY, Quan ZW,Zhang Q, et al. The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma. BMC Cancer,2007,7:125.
5Raderer M, Hejna MH, Muller C, et al. Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo. Int J Oncol,2000,16:1197-1201.
6Hejna M, Zielinski CC. Nonsurgical management of gallbladder cancer: cytotoxic treatment and radiotherapy. Expert Rev Anticancer Ther,2001,1 : 291-300.
7Todoroki T. Chemotherapy for gallbladder carcinoma-a surgeon's perspective. Hepatogastroenterology ,2000,47 : 948-955.
8Gewirlz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol, 1999,57:727- 741.
9Kim R, Ohi Y, Inoue H, et al. Expression and relationship between topoisomerase Ⅰ and Ⅱ alpha genes in tumor and normal tissues in esophageal, gastric and colon cancers. Anticancer Res, 1999, 19 : 5393-5398.
10Nitiss JL, Liu YX, Harbury P, et al. Amsacrine and etoposide hypersensitivity of yeast cells overexpressing DNA topoisomerase Ⅱ. Cancer Res, 1992,52: 4467-4472.
